Prakash Raman
Chief Executive Officer at InduPro
Prakash Raman is Chief Executive Officer at InduPro. He has previously held leadership and scientific roles at AstraZeneca, Flagship Pioneering, Millennium Pharmaceuticals, and Novartis.
InduPro raises $77M Series B, doses first patient in Phase 1 trial of IDP-001 targeting tumor protein pairs
InduPro raised $77 million in Series B financing and has dosed the first patient in a Phase 1 trial of IDP-001, an antibody-drug conjugate that uses the company’s ARRIS platform to target cancer cells by bringing two surface proteins together.
InduPro Raises $77M Series B Led by The Column Group and Doses First Patient in Phase 1 Trial of IDP-001
InduPro closed a $77 million Series B financing led by The Column Group and dosed the first patient in a Phase 1 trial of IDP-001, a bispecific antibody-drug conjugate targeting EGFR and a novel tumor-associated proximity antigen for advanced squamous NSCLC and other solid tumors.
Organizations
See all 8-
InduPro Chief Executive Officer 2024–present · current
-
Ribon Therapeutics President and CEO 2022–2024 · past
-
Flagship Pioneering Senior Partner, Chief Business Development Officer 2019–2022 · past
Education
-
University of Wisconsin-Madison Ph.D., Organic & Medicinal Chemistry · 1991–1997
-
Indian Institute of Technology, Bombay M.S., Organic Chemistry · 1986–1991
-
vivek vidyalaya 1982–1984
-
Kabwe Secondary School 1980–1982
